Zobrazeno 1 - 10
of 233
pro vyhledávání: '"John B, Robbins"'
Autor:
Reut Ramon-Saraf, Evgeny Vinogradov, John B. Robbins, Shai Ashkenazi, Rachel Schneerson, Nahid Farzam, Joanna Kubler-Kielb, Liat Lerner-Geva, Yonit Banet-Levi
Shigella flexneri (S. flexneri) 6 has emerged as an important cause of shigellosis. Our efficacy study of Shigella sonnei and S. flexneri 2a O-specific polysaccharide (O-SP) conjugates in 1–4 year-olds had too few S. flexneri 2a cases for efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7285f80e238bd7d0ae23c552fd0d948a
https://nrc-publications.canada.ca/eng/view/object/?id=6116bfcd-97e8-44fb-b99e-4b392d2c072e
https://nrc-publications.canada.ca/eng/view/object/?id=6116bfcd-97e8-44fb-b99e-4b392d2c072e
Autor:
John B. Robbins, Justen H. Passwell, Rachel Schneerson, Hadas Even-Nir, Liat Lerner-Geva, Shai Ashkenazi, Joseph Shiloach, Chiayung Chu, Nahid Farzam, Reut Ramon-Saraf, Baruch Yerushalmi, Yonit Banet-Levi
Publikováno v:
Vaccine. 37:5504
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b1757a08ac22f47ef3584eea57e0b1c
https://doi.org/10.1016/j.vaccine.2019.07.065
https://doi.org/10.1016/j.vaccine.2019.07.065
Autor:
Birgit Thierry-Carstensen, Tine Dalby, John B. Robbins, Michael A. Stevner, Rachel Schneerson, Birger Trollfors
Publikováno v:
Vaccine. 31:5178-5191
Combination vaccines containing a monocomponent acellular pertussis (aP) vaccine, manufactured at Statens Serum Institut (SSI), Denmark, have successfully controlled Bordetella pertussis infections in Denmark since 1997. The efficacy of this aP vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71011a3428797be0699d5c7b621f7542
https://doi.org/10.1016/j.vaccine.2013.08.034
https://doi.org/10.1016/j.vaccine.2013.08.034
Autor:
Xiaomei Tan, Shousun C. Szu, Guilin Xie, Zhigang Zhao, Steven Hunt, Rajesh Gupta, John B. Robbins, Rachel Schneerson
Publikováno v:
Vaccine. 31:1970-1974
Recent data showing the high incidence of typhoid fever in young children, the demonstration of safety and efficacy of a Vi conjugate for this age group, the safety and similar immunogenicity in infants when administrated concurrently with EPI vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7776d887f8619e0f8d7b640b5769691d
https://doi.org/10.1016/j.vaccine.2013.02.006
https://doi.org/10.1016/j.vaccine.2013.02.006
Publikováno v:
New Generation Vaccines ISBN: 9780429130090
TYPHOID FEVER Typhoid fever, which is transmitted to susceptible hosts by food and water contaminated with S. typhi, remains a major health problem in developing countries. Since the 1990s, the emergence of antibiotic resistant strains has made the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12033dbe2499ccf27893eb7ce80c206e
https://doi.org/10.3109/9781420060744-51
https://doi.org/10.3109/9781420060744-51
Publikováno v:
Lancet. 11/9/1996, Vol. 348 Issue 9037, p1289. 4p. 3 Charts.
Autor:
John B, Robbins, Rachel, Schneerson, Guilin, Xie, Lars Å, Hanson, Lars, Åke-Hanson, Mark A, Miller
Publikováno v:
Proceedings of the National Academy of Sciences. 108:17871-17875
We reviewed the literature that is the basis for our proposal that (2→8)-α-Neu5Ac conjugates will be safe and effective vaccines for Group B meningococci (GBMs), Escherichia coli K1, and Pasteurella haemolytica A2. Although (2→8)-α-Neu5Ac is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2250cfac062c67f2c06d157f97fb60
https://doi.org/10.1073/pnas.1114489108
https://doi.org/10.1073/pnas.1114489108
Autor:
Shengqing Yu, Artur Muszyński, John B. Robbins, Russell W. Carlson, David J. Lim, Chao Ming Tsai, Ronald S. Petralia, Song Gao, Dabin Ren, Xin Xing Gu, Daxin Peng
Publikováno v:
Vaccine. 29:4210-4217
There is no licensed vaccine available against Moraxella catarrhalis, an exclusive human pathogen responsible for otitis media in children and respiratory infections in adults. We previously developed conjugate vaccine candidates based on lipooligosa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f4d0dce8ab4fd929b279cbdaafd74e2
https://doi.org/10.1016/j.vaccine.2011.03.102
https://doi.org/10.1016/j.vaccine.2011.03.102
Autor:
Feng-Ying C. Lin, Shousun C. Szu, John B. Robbins, Rachel Schneerson, Vu Dinh Thiem, Steven Hunt, Nguyen Hong Son, Do Gia Canh, Nguyen Duc Mao, Chiayung Chu, Dang Duc Anh
Publikováno v:
Clinical and Vaccine Immunology. 18:730-735
Typhoid fever remains a serious problem in developing countries. Current vaccines are licensed for individuals who are 5 years old or older. A conjugate of the capsular polysaccharide (CP) of Salmonella enterica serovar Typhi (Vi) bound to recombinan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c386a9c164cb89be73713e29d1996a5
https://doi.org/10.1128/cvi.00532-10
https://doi.org/10.1128/cvi.00532-10
Autor:
Martina V. Nardini, Ingi Karl Reynisson, Magnus Gottfredsson, Hafrún Kristjánsdóttir, John B. Robbins, Mark A. Miller, Jon Fridrik Sigurdsson, Ragnar Freyr Ingvarsson, Rachel Schneerson
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
No vaccine is universally active against serogroup B meningococci. A theoretical concern that serogroup B capsular polysaccharide may induce autoimmunity hampers vaccine development. We studied long-term complications in 120 survivors of meningococca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b879f174c4a880ab718d331648435d86
http://europepmc.org/articles/PMC3189164
http://europepmc.org/articles/PMC3189164